XML 81 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 8,962,686 $ 33,718,713
Restricted cash 34,174 634,416
Total cash, cash equivalents, and restricted cash 8,996,860 34,353,129
Short-term investments 28,277,386  
Accounts receivable 1,021,179 3,461,938
Tax refund receivable 629,096 1,008,973
Prepaid expenses and other current assets 470,228 548,094
Total current assets 39,394,749 39,372,134
Property and equipment, net 1,104,208 1,342,802
Right of use asset 698,321  
Intangible assets, net 12,732,195 13,851,924
Other assets 128,547 183,682
Total assets 54,058,020 54,750,542
Current liabilities:    
Notes payable   71,596
Accounts payable 18,232 372,860
Accrued expenses and other current liabilities 3,904,767 4,082,949
Total current liabilities 3,922,999 4,527,405
Deferred income taxes   58,500
Contingent consideration 2,750,000  
Other long-term liabilities 1,864,875 1,852,071
Total liabilities 8,537,874 6,437,976
Commitments and contingencies (Note 16)
Stockholders’ equity:    
Common stock, $0.0001 par value; 200,000,000 shares authorized; 15,312,381 and 9,078,735 shares issued; 15,312,167 and 9,078,238 shares outstanding at December 31, 2019 and 2018, respectively 1,508 876
Additional paid-in capital 187,914,916 170,207,844
Accumulated deficit (137,376,122) (116,855,991)
Accumulated other comprehensive loss, net (5,020,156) (5,040,163)
Total stockholders’ equity 45,520,146 48,312,566
Total liabilities and stockholders’ equity $ 54,058,020 $ 54,750,542